Armis Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Armis Advisers's AMGN Position: Q3 2026 in Review
Armis Advisers increased its Amgen (AMGN) stake by 0.7% in Q3 2026, buying an estimated $17.9K and bringing the position to 6,463 shares worth $2.7M. The position accounts for 0.23% of the portfolio, ranked #80.
Armis Advisers first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Armis Advisers held 6,463 shares of Amgen worth $2.7M as of Q3 2026.
- Armis Advisers bought 45 Amgen shares in Q3 2026, an estimated $17.9K.
- Amgen made up 0.23% of Armis Advisers's portfolio in Q3 2026, its #80 holding.
- Armis Advisers first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
- 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.